Celldex Therapeutics (CLDX)
(Delayed Data from NSDQ)
$40.17 USD
-1.07 (-2.59%)
Updated Sep 23, 2024 04:00 PM ET
After-Market: $40.14 -0.03 (-0.07%) 5:38 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/07/2024
Time: -- |
9/2024 | $-0.69 | 0.00% |
Earnings Summary
For their last quarter, Celldex Therapeutics (CLDX) reported earnings of -$0.54 per share, beating the Zacks Consensus Estimate of $-0.59 per share. This reflects a positive earnings surprise of 8.47%. Look out for CLDX's next earnings release expected on November 07, 2024. For the next earning release, we expect the company to report earnings of -$0.69 per share, reflecting a year-over-year increase of 14.81%.
Earnings History
Price & Consensus
Zacks News for CLDX
Acadia Healthcare (ACHC) Beats Q2 Earnings and Revenue Estimates
CLDX: What are Zacks experts saying now?
Zacks Private Portfolio Services